Objective: To assess the prevalence, clinical presentation, therapeutic management and medium-term prognosis of spontaneous coronary artery dissection (SCAD). Methods: Over a 5-year period, and out of a cath-lab database of 11,605 files, 23 cases of SCAD were confirmed by reanalysis of angiograms. Therapeutic management and in-hospital outcome were obtained from medical files and prospective follow-up was performed. Results: The population consisted of 17 women and 6 men (mean age 45 years). A total of 83% of men had !2 cardiovascular risk factors versus only 35% of women ( p = 0.07). Acute coronary syndrome (ACS) was the clinical presentation in 21 cases (ST+ 61%). The prevalence of SCAD was: 0.2% in the whole population (men: 0.07%, women: 0.6%, p < 0.001), and 8.7% and 10.8% in women <50 years with ACS and ST+ ACS, respectively. Left and right coronary arteries were involved in 20 (87%) and 3 (13%) cases, respectively. Coronary stenting alone was performed in 8 (35%), bypass surgery alone in 2 (9%), and both in 3 (13%) cases. Ten patients (44%) were medically managed. One patient died during hospitalization. At 1-year follow-up (100%), 77% of discharged patients were event-free. One patient died, four experienced heart failure, and none had angina or new ACS. Conclusion: SCAD is observed in as much as 1 out 10 women <50 years presenting with ACS. After immediate coronary angiography, medical therapy is the chosen strategy in half of cases. Most patients who survive the acute phase are free from coronary events at 1 year. #
Introduction
Spontaneous coronary artery dissection (SCAD) is an infrequent disease, which has been found to be associated with various pathophysiological situations, such as pregnancy, postpartum, collagen diseases, cocaine abuse, severe hypertension, smoking, oral contraceptives, heavy exercise, or vasospasm [1] . It was first described in 1931 after a necropsy of a 42-year-old woman who died suddenly [2] , and the first angiographic report occurred almost 50 years later, in a 55-year-old woman with acute myocardial infarction [3] . Surgical revascularization and percutaneous transluminal coronary angioplasty (PTCA) for SCAD were then reported in the mid 1980s [4, 5] . Several case reports and a small series of patients suffering from SCAD have been reported since [6] [7] [8] [9] [10] [11] , with prevalence of the disease ranging from 0.2% to 1.1% of coronary angiographies performed for stable angina or acute coronary syndromes (ACS). However, 75 years after the first report, the rarity, the wide spectrum of clinical presentation, the absence of consensual treatment, and the few data available regarding short-and long-term prognosis make the management of patients presenting with SCAD a challenge every time.
Accordingly the aim of the present study was to assess the prevalence, the clinical presentation, the therapeutic workout and the in-hospital and long-term prognosis of SCAD in a single large volume university cardiology department. post-traumatic coronary artery dissection, 23 patients presenting with SCAD were retrospectively identified. The diagnosis was defined on coronary angiography by the presence of an intimal flap with false lumen, and/or a stagnation of contrast media in the coronary artery wall. Clinical and biological data were then obtained from medical files. Patients were prospectively followed as usually performed in our group after acute coronary syndrome, with a cardiology review and an exercise stress test or myocardial perfusion imaging. For deceased patients, or if otherwise needed, information was obtained by telephone from the family and/or the patient's GP or cardiologist. Predetermined primary end point was a composite of cardiac deaths (sudden death and death caused by myocardial infarction or congestive heart failure), non-fatal myocardial infarction (defined by the appearance of new Qwaves on ECG), and heart failure.
Patients and methods
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Baseline data (Table 1)
The study population consisted of 17 women (74%) and 6 men (26%), with a mean age of 46 AE 9 years [median = 45, range 30-69] without significant difference between sexes. The averaged number of cardiovascular risk factors (1.4 AE 1.2 for the whole population) was higher in men (2.2 AE 1.2, median = 2) than in women (1.2 AE 1.2, median = 1, p = 0.07); 5/6 men (83%) presented with 2 or more risk factors versus 6/17 women (35%, p = 0.07). Clinical presentation was an ACS in 21 cases (91%), with and without persistent ST-elevation in 7 (33%) and 14 (67%) cases, respectively. Among patients presenting ST elevation ACS, four underwent pre-hospital thrombolysis, which was successful in only one. One patient presented initially with cardiogenic shock and two had experienced resuscitated ventricular arrhythmias. No patient, except one women with type IV-Ehlers-Danlos syndrome, had any coexisting history or physical examination suggesting inflammatory, immune system or collagen disease, and none of the women were pregnant or in the postpartum period.
The coronary artery involved was the left main, the left anterior descending, the left circumflex, and the right coronary artery in 3 (13%), 12 (52%), 5 (22%) and 3 (13%), respectively. Initial TIMI flow was 0-1 in 14 patients (61%), 2 in 5 patients (22%), and 3 in only 4 patients (17%). Angiographically visible atheromatous CAD without significant stenosis (>50%) was present in only 5 patients (22%). Intimal flap with false lumen and/or contrast median stagnation were observed in 15 (65%) and 13 (56%) of the patients, respectively.
Prevalence of SCAD in the study population
The overall prevalence of SCAD in the study population was 0.20% (23/11,605), and was higher in women than in men: 0.60 (17/2833) versus 0.07% (6/8772), (RR 8.78 [3.46-22 .24], (Fig. 1) .
Therapeutic management
First therapeutic option was medical treatment alone in 10 patients (43%) and coronary revascularization in 13 patients (57%): coronary artery bypass surgery (CABG) in 2 (9%) and PTCA with bare metal stent deployment in 11 (48%). PTCA was successful in 8 patients, but lead to immediate or delayed (<48 h) extension of the dissection requiring emergency CABG in 3 patients. Overall five patients underwent elective or emergency CABG (Fig. 2) . Revascularization procedures were mainly performed in patients with dissection involving the left main coronary artery and the proximal or mid LAD, while medical therapy was the preferred strategy in other locations. Indeed, 100% of patients with left main or proximal or mid LAD involvement underwent a CABG or a PCI, versus only 17% in others cases ( p < 0.01) (Fig. 3) .
Cardiac events
Two patients died (8.7%): one from cardiogenic shock during the in-hospital period (day 3) and one from sudden death 12 months after discharge. During follow-up (median duration 15.6 months, 100% completed), four patients developed NYHA class 2 or 3 heart failure, none had recurrence of angina or ACS, and none required repeated coronary revascularization. Accordingly, 1-year event free survival was 74% in the overall population, and 77% among the 22 patients who survived the acute phase (Fig. 4) .
Out of the 21 survivors, 17 (81%) underwent an exercise stress test alone (n = 5) or coupled with myocardial perfusion imaging (n = 12) 6-12 months after discharge. None of them had positive EST or significant ischemia as defined by a reversible myocardial perfusion defect involving more than 10% of the left ventricle. Therefore, none of 21 survivors experienced any ischemic event during the following 15 months.
Discussion
The prevalence of SCAD in our series (0.20%) confirms the infrequency of this disease in patients undergoing coronary angiography for stable CAD or ACS. Our findings are consistent with previous angiographic series reporting prevalence ranging from 0.10% to 0.24% [6] [7] [8] [9] 11] . Only Hering et al. reported a much higher prevalence of 1.10% in a prospective series using intra-vascular ultra-sound [10] .
It is usually admitted that SCAD occurs in women in 75% of the cases [12] , one third of them being in the postpartum period [13] , with a mean age of onset below 35 years [11] . As with other investigators, we found that SCAD was 8-9 times more frequent in women, who accounted for 74% of our study population. However, the mean age of our female population was 46, higher than that usually stated [6] [7] [8] [9] . None of them was pregnant or in the postpartum period, and none, except one with Ehlers-Danlos syndrome, had any coexisting history or physical examination suggestive of inflammatory, immune system or collagen disease. Conversely, although to a lesser extent than in men, most women in our study (70.6%) had one or more cardiovascular risk factors. As suggested by Celik et al. [11] , this finding supports the hypothesis that the etiologies of SCAD can be primarily divided in two groups: non-atherosclerotic and atherosclerotic CAD. SCAD is therefore not an uncommon cause of ACS in middle-age women, as it occurred in our series in 1 out of 10 women <50 years of age presenting with ST elevation acute myocardial infarction. The responsibility of emotional stress [14] or exertion [10] in SCAD is also often quoted. For example, in the series by Hering et al., 12 out of the 42 cases (28%) occurred after intense exercise [10] ; such setting was only found in 4 out of our 23 patients. Finally, SCAD may occur in the absence of any identified cause, as recently reported by Vavuranakis et al. in two women without evidence of atherosclerotic CAD detected by IVUS, low CRP values, and no inflammatory lesion as assessed by intra-coronary thermography [1] .
Optimal management of SCAD is not clearly defined. Possible options include conventional medical therapy, or invasive therapies such as CABG or PTCA with coronary stenting [15] . Thrombolysis has been successfully used as a therapy [16] , however there have been case reports of deleterious results with extension of the dissection following thrombolysis [17, 18] . Only four patients presenting ST elevation ACS underwent pre-hospital thrombolysis in our series, which failed to achieve successful reperfusion in three cases. The severity and extent of coronary dissection was not found however to be greater in patients with than without thrombolysis. The decision to pursue medical management, percutaneous coronary intervention, or surgical revascularization is based primarily on the clinical presentation, extent of dissection, and amount of ischemic myocardium at risk [19] . In our study, both patients who underwent CABG as first choice therapy had involvement of left main coronary artery. Out of the three patients with PTCA followed by CABG because of symptomatic secondary extension of the dissection, SCAD was located on the left main and proximal LAD in one and two cases, respectively. All five patients had initial dissection >2 cm length. Of note, surgery remains difficult in these circumstances, because of the thinness and/or residual dissection of the coronary arteries. As proposed by Celik et al. [11] , it seems reasonable to propose that PTCA with stent deployment should be applied to dissections having limited extension and causing narrowing of lumen less than 50% [20] . CABG surgery should probably be the most preferred treatment in extensive SCAD, especially when it involves the left main artery or proximal LAD, with a large amount of downstream jeopardized myocardium. However, PTCA prior to surgery is mandatory in patients with occlusive dissection and TIMI 0-1 flow, in order to limit infarct size waiting for surgery. Finally, medical therapy alone may be an option in mid-or distal SCAD, without lumen diameter limitation >50%, and with TIMI 2 or 3 flow. Indeed none of the 10 patients medically treated in our series underwent any serious adverse event at follow-up.
In-hospital mortality of SCAD is relatively low, with a mean value around 3% [0-4%] [6] [7] [8] [9] [10] [11] 21] . Patients who survive the acute phase have good long-term prognosis, with a very low recurrence rate of SCAD [10] or acute coronary syndrome [10, 21] , and a 95% 2-year survival rate in the meta-analysis from Thompson et al. [22] . Our results are concordant with previously published data, as among discharged patients (and at 15-month follow-up), only one died (4.5%), none experienced any ischemic event, and 77% were totally event-free (Table 2 ). Pooling data of 222 patients from several publications, Thompson et al. found that multivariate predictors of death included female sex (odds ratio 4.27) and absence of early treatment (odds ratio 35.5). The size of our study population was not large enough to perform such analysis.
In conclusion, although SCAD is an uncommon disease in the general population, especially in men, it may be responsible for more than 10% of ST elevation ACS in women below 50 years of age. Opposite to what is usually thought, it is not only the disease of younger women in the peripartum period, or carrying inflammatory or collagen disease, but can be seen in middle-aged females with one or more cardiovascular risk factors. Although initial treatment is not standardized and the choice between medical therapy, PTCA or CABG is left at the physician's discretion, a large majority of patients who survive the acute phase are free from event at follow-up.
